Current management of stage IB2 and bulky IIA, locally advanced, and recurrent cervical carcinoma
Cervical cancer is one of the most common cancers affecting women, with most early disease treated with either surgery or radiation alone with an 85%-95% 5-year survival rate, while locally advanced cervical cancer (LACCA) requires multiple therapeutic modalities. The clear distinction between early...
Saved in:
Main Authors: | Karen K. Lo (Author), Anne O. Rodriguez (Author), Janice Ryu (Author), Vijay P. Khatri (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical analysis of 312 patients with stage IB1-IIA2 cervical squamous cell carcinoma and research on the influencing factors of postoperative recurrence
by: Jia Zeng, et al.
Published: (2023) -
Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy
by: Peng-Hui Wang, et al.
Published: (2014) -
Recurrence-Free Survival Stage IB1-IIA2 Intermediate Risk Group (Based on Kartu Delgado) Cervical Carcinoma after Radical Surgery and Adjuvant Radiotherapy
by: Andi Friadi, et al.
Published: (2014) -
Outcomes of Treatment for Cervical Cancer Stage IB2 and IIA2; Radical Hysterectomy and Definitive Radiotherapy
by: Teeraphong Narukon, et al.
Published: (2010) -
Caspase-3 can not be Used to Predict the Response to Neoadjuvant Chemotherapy Regiment PVB in Cervical Cancer Stage IB-IIA
by: Ediwibowo Ambari, et al.
Published: (2013)